Journal article
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
Abstract
BACKGROUND: The direct oral thrombin inhibitor dabigatran has a predictable anticoagulant effect and may be an alternative therapy to warfarin for patients who have acute venous thromboembolism.
METHODS: In a randomized, double-blind, noninferiority trial involving patients with acute venous thromboembolism who were initially given parenteral anticoagulation therapy for a median of 9 days (interquartile range, 8 to 11), we compared oral …
Authors
Schulman S; Kearon C; Kakkar AK; Mismetti P; Schellong S; Eriksson H; Baanstra D; Schnee J; Goldhaber SZ
Journal
The New England Journal of Medicine, Vol. 361, No. 24, pp. 2342–2352
Publisher
Massachusetts Medical Society
Publication Date
December 10, 2009
DOI
10.1056/nejmoa0906598
ISSN
0028-4793